Vancouver-based biotech company central in development of Pfizer COVID-19 vaccine

vancouver based biotech company central in development of pfizer covid 19 vaccine

Sumary of Vancouver-based biotech company central in development of Pfizer COVID-19 vaccine:

  • A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus..
  • Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a surprisingly robust 90 per cent effective at preventing COVID-19..
  • Vancouver-based Acuitas Therapeutics, a biotechnology company, is playing a key role through a technology known as lipid nanoparticles, which deliver messenger RNA into cells..
  • “The technology we provide to our partners is lipid nanoparticles and BioNTech and Pfizer are developing a vaccine that using a messenger RNA that tells our cells how to make a protein that actually found in the COVID-19 virus,”.
  • Trudeau reacts to news Pfizer coronavirus vaccine may be 90% effective The idea around using messenger RNA for vaccines is a new technology, Madden said, and the development of the COVID-19 vaccine is the “most important”.
  • “Everybody was hopeful the vaccines would provide protection and this is the first demonstration that that is indeed the case.”.
  • 2:05 Canada inks deals to secure millions of coronavirus vaccine doses Canada inks deals to secure millions of coronavirus vaccine doses – Aug 5, 2020 Acuitas Therapeutics employs 29 people and Madden said he believes everyone is feeling very proud of their work…

Want to know more click here go to health news source.

From -

Close

Languages